BCAL Diagnostics Limited

ASX:BDX Stock Report

Market Cap: AU$37.7m

BCAL Diagnostics Limited Company Information

BCAL Diagnostics Limited's employee growth, exchange listings and data sources

Key Information

  • Name: BCAL Diagnostics Limited
  • Ticker: BDX
  • Exchange: ASX
  • Founded: 2010
  • Industry: Biotechnology
  • Sector: Pharmaceuticals & Biotech
  • Market Cap: AU$37.660m
  • Shares Outstanding: 358.66m
  • Website: https://www.bcaldiagnostics.com

Location

  • BCAL Diagnostics Limited
  • 50 Clarence Street
  • Suite 506
  • Sydney
  • New South Wales
  • 2000
  • Australia

Listings

TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
BDXASX (Australian Securities Exchange)YesOrdinary SharesAUAUDJul 2021
BDXCHIA (Chi-X Australia)YesOrdinary SharesAUAUDJul 2021

Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2024/11/04 20:44
End of Day Share Price 2024/11/04 00:00
Earnings2024/06/30
Annual Earnings2024/06/30


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.